EU-JAV Sixth Newsletter

Written by laure vidal on March 31, 2022 in All news Dissemination

6th EU-JAV Newsletter March 2022

Welcome to the sixth JAV newsletter!

‘Dear Partner,

Welcome to our last newsletter, as the project is coming to its end on the 31st of March 2022.

As for the previous ones, we want to inform you on what kept us busy, and to provide information on EU-JAV advances.

After more than three and a half years of work, the EU Joint Action on Vaccination leaves concrete tools and recommendations to strengthen cooperation in Europe in the vaccination field. We are hoping that you appreciated being with us during these years, following our different reports, surveys, reviews, and meeting, and that you will keep getting information on vaccination in the future.

Have a good week and enjoy your reading!’

Introduction by Olivier Epaulard, Coordinator of the Joint Action, INSERM

Dear all,

Launched in the Summer 2018, the EU-JAV will come to an end at the end of March 2022. After more than 3 years and half (with an 8-month extension due to the burden of Covid-19), we will finally have achieved the launch of three platforms (one for the visualisation of vaccine coverage at a supranational level, one for the visualisation of the vaccination-centered conversation in the social media and more broadly online, and one for the gathering of reports of initiatives and actions conducted in Europe regarding vaccine hesitancy and uptake and their analysis); we also delivered many reports regarding various aspects of the vaccination, and how to obtain better scientific research and research funding, better anticipation of needs and procurement, better evaluation of vaccine coverage, better training of healthcare professionals, and better communication toward Youth, and how to carry out such actions at a supranational level.

In addition to these tools and to the documents describing these survey and analysis, we are preparing recommendations and policy briefs to help stakeholders, policy-makers, and political leaders to make these results their own and include them into their actions regarding the health of European populations.

Indeed, March 2022 may be the last month of the consortium, but the EU-JAV legacy will endure, thanks to the commitment of all: we aimed it will be a game-changer at the scale of the continent.

Thank you for being with us along the way; and please, consider yourself the recipient all the EU-JAV production!

Yours,

O.Epaulard

EU-JAV coordinator

Main Results of the EU-JAV

To monitor and address the pre-service and in-service needs of healthcare students and professionals, two tools were elaborated and tested: a “vaccine barometer”, which allows measuring the skills and the needs of participants regarding vaccination knowledge and practice; and a complete curriculum on vaccination, which addresses all the different relevant topics in the field. Each country and each healthcare student/professional association can make its own these tools and improve the impact of these crucial agents on vaccine uptake.

Two communication actions toward Youth were implemented; they consisted of two competitions for the elaboration of posters and videos promoting HBV and HPV vaccination. These actions were successful, and were opportunities to determine how some wider, future actions should be designed and launched.

platform to monitor and compare at national and subnational levels harmonised vaccine coverage was built upon a specific extension of the software R; with the example of measles-containing vaccines, it allows to identify immunisation gaps in spite of the complexity resulting from the difference of vaccines schedules between different countries.

A study of the existing reminder systems was performed in 17 countries. Such systems are designed to ensure that as many individuals as possible will receive the recommended vaccines. All countries have reminder systems in place but the study highlighted the heterogeneity of these systems between European countries both the nature and the extension of the systems.

A survey of the prerequisites, the operational implementation, and the perceived barriers and enablers for conducting cross-borders vaccination campaigns was performed through questionnaires and workshops with 28 European countries; it paves the way to implement such international actions focused on a cross-border area.

study of past vaccine shortages experiences was conducted; it allows identifying the vaccines involved and the causes (often multiple) of such shortages, and to emit recommendations to prevent these episodes.

study of financing mechanisms and of the feasibility of joint vaccine procurement (gathering EU member states) instead of national procurement was conducted, and led to a better understanding of how the ecosystem of vaccine procurement may evolve in the near future. In addition, a survey on the stockpiling of vaccines and the exchanges of vaccine stockpiles between EU member states has been conducted.

A method to consensually identify research priorities in vaccination has been elaborated, and was applied in 2020 and 2021 to set annual lists of the most relevant research topics that should receive attention and funding in the near future.

A survey regarding the mechanisms that may lead entities that provide research funds to collaborate and adopt joint funding to increase the efficiency of the research has been conducted.

platform to gather as much as possible documents accounting for past experiences of EU member states in their efforts to address vaccine hesitancy has been launched; the many features on this platform allow to identify the best practices and the most efficient action in this field.

A platform that displays the monitoring of the vaccine confidence as expressed in the social media and the content of the online conversation regarding vaccine and vaccination has been elaborated.

Final Conference

March 9th, 2022

in PARIS

The European Joint Action on Vaccination (EU-JAV), co-funded by EU’s Health Program and the European Health and Digital Executive Agency (HaDEA), is pleased to inform you of its final conference.

Since 2018, teams from 20 EU/EEA countries have worked together to design, develop and propose a common approach towards a strengthened, winning fight against vaccine-preventable diseases within Europe.

The different teams that collaborated in this Joint Action presented the results of their work, the conclusions reached after thorough research and detailed scientific analysis, and their recommendations for -doable- European-wide actions against vaccine-preventable diseases.

The EU-JAV Final Conference was a hybrid event: it took place in Paris, France, and also online.

For more information visit eu-jav.com or follow EU-JAV social media accounts (@eujav @eu__jav)

On behalf of

all the partners – EU-JAV consortium, EU and non-EU Member States,

National Public Health Organization (NPHO / EODY) – Greece, and Inserm – France

Deliverables of the EU-JAV

Deliverable D2.2
Stakeholder Mapping

The following deliverable is part of Work package 2 – task 2.2 of EU-JAV which aims at informing all project work-packages, particularly concerning their outreaching activities and actions, such as communication activities for project promotion or research. It was made by Hellenic Center for Disease Control and Prevention (HCDCP).

Deliverable D2.4
Strategic Dissemination Plan

The following deliverable is part of Work package 2 – task 2.4 of EU-JAV which sets out a strategy for the dissemination of information stemming from the EU-JAV (European Joint Action on Vaccination) activities and results. It outlines a plan to connect the relevant target audiences with EU-JAV by means of appropriate communication tools. It was made by HCDCP and EODY/NPHO.

Deliverable D3.2
Midterm Evaluation Report

The following deliverable is part of Work package 3 – task 3.2 of EU-JAV which aims to evaluate the process of the work packages (WP), as well as program meetings. It was made by FOHM.

Deliverable 4.6
Methodology and plan for pilot study, and draft plan for extended study, regarding the decision-making process of national immunisation technical advisory groups (NITAGs)

The following deliverable is part of Work package 4 – task 4.3.2.1 of EU-JAV which aims at characterizing the decision-making process of different NITAGs countries regarding the inclusion of vaccines in their national immunization schedules. It was made by FMS.

Deliverable D6.1
Report on Previous Experiences with Vaccines Shortages in EU Countries (and non-EU consortium member countries), and Responses at National and European Level

The following deliverable is part of Work package 6 – task 6.1.3 of EU-JAV which refers to the objective: Analyze and evaluate local financing mechanisms for purchase and stock of vaccines. It was made by ISS.

Deliverable D6.4
Report on Understanding Mechanisms for Defining the Anticipated Needs to Ensure Sufficient Size of Supply and Stockpiles, including their sustainability

The following deliverable is part of Work package 6 – task 6.2 of EU-JAV which consist on the creation of a report on the anticipated needs to ensure sufficient size and suppy and stockpiles including their sustainability. It was made by FHI.

Deliverable D7.1
Guidelines / Best Practices to Establish Priorities for Vaccines and Vaccination Research to Increase Vaccination Coverage

The following deliverable is part of Work package 7 – task 7.1 of EU-JAV which aims to define and apply a concept framework for decision-making on research priorities for an agreed subset of vaccines. It was made by Inserm.

Deliverable D7.1.2
Second Annual List of Research Priorities on Vaccination

The following deliverable is part of Work package 7 – task 7.1.2 of EU-JAV which refers to the outcome of the final face-to-face meeting of experts, which allowed the articulation of a second list of priorities on vaccination. It was made by Inserm.

Deliverable D8.1
Vaccine hesitancy and uptake. From research and practices to implementation 

This report presents the results of the work done in the EU Joint Action on Vaccination (EU-JAV) Work Package 8 (WP8) task 8.1. The aim of task 8.1 is to develop a systematic overview and analysis of the current situation of activities related to vaccine hesitancy and uptake, including best practices and lessons learned in the Member States and their regions. This report has been written by the EU-JAV team at the Finnish Institute for Health and Welfare (THL) leading this work in the EU-JAV.

Deliverable D2.3
Leaflet

The following deliverable is part of Work package 2 – task 2.2 of EU-JAV which aims at informing all project work-packages, particularly concerning their outreaching activities and actions, such as communication activities for project promotion or research. It was made by Inserm.

Deliverable D3.1
Evaluation Plan

The Evaluation Plan describes the objectives and targets of the Joint Action on Vaccination, as well as the methodology, indicators and time plan to be used in the evaluation of the Joint Action on Vaccination. It was made by FOHM.

Deliverable D4.5
Report on Communication Pilots

The following deliverable is part of Work package 4 – task 4.5 of EU-JAV which refers to the objective: to implement pilot actions to explore the feasibility of joint undertakins on vaccine-related issues. It was made by ECL.

Deliverable 5.3
Report on standardized estimations of vaccine coverage

The following deliverable is part of Work package 5 – task 5.3 (WP5.2) of EU-JAV which aims to establish common methodological guidelines, data structure and criteria for standardized assessment of vaccination coverage. It was made by Statens Serum Institut (SSI).

Deliverable D6.3
Report on financial mechanisms for vaccine procurement, based on a survey among EU/EEA and EU-JAV consortium Member States

The following deliverable is part of Work package 6 – task 6.1.3 of EU-JAV which refers to the objective: Analyze and evaluate local financing mechanisms for purchase and stock of vaccines. It was made by ISS.

Deliverable D6.5
Report on Possibilities, Gasps and Options for building a 'Concept Type' for Regional or European Virtual Stockpiles on Vaccine Management Needs and Stocks

The following deliverable is part of Work package 6 – task 6.2 of EU-JAV which aims to understand if a virtual stock-pile-monitoring tool or other type of rapid exchange mechanism could be useful and if such a tool should be restricted to specific vaccines only to secure public health and national security. It was made by FHI.

Deliverable D7.1.1
First Annual List of Research Priorities on Vaccination

The following deliverable is part of Work package 7 – task 7.1.1 of EU-JAV which aims to set up the first annual list of research priorities on vaccination. It was made by Inserm.

Deliverable 7.2
Second Annual List on Research Priorities on Vaccination

The following deliverable is part of Work package 7 – task 7.2 of EU-JAV which refers to the outcome of the final face-to-face meeting of experts, which allowed the articulation of a second list of research priorities on vaccination. It was made by Inserm.

Latest News

European Commission – Call for Tender on Vaccination 2

For your information, on 21 February 2022, HaDEA ( European Health and Digital Executive Agency) published a call for tenders, by means of which the Commission wants to support Member…

European Commission – Call for Tender on Vaccination

Service Contract to Identify Obstacles to Vaccination of Physical, Practical or Administrative Nature and Develop RecommendationsDear EU-JAV Partners,    For your information, on 11 January 2022, HaDEA ( European Health…

WP4 – The Lancet

WP4 team has written an article for The Lancet that describes their work within the EU-JAV.

Digital workshops on cross border vaccination campaigns

Last week on 24 and 26 November, the Swedish Public Health Agency hosted 2 digital workshops to discuss cross border vaccination campaigns.

© INSERM 2018, Website Created by FMOSys